As the importance of understanding of the patient journey increases, longitudinal research provides us a comprehensive look into a particular experience.
Read more
As the importance of understanding of the patient journey increases, longitudinal research provides us a comprehensive look into a particular experience.
As the importance of understanding of the patient journey increases, longitudinal research provides us a comprehensive look into a particular experience.
Whether you are looking to incorporate a platform strategy or create a novel device, understanding the Patient Journey is crucial to developing an effective and successful pharmaceutical delivery system. Learn why we firmly believe that a contextual understanding of the patient’s experience is so important.
Collaboration between Human Factors Engineers and Designers is crucial for cultivating an understanding of individual goals and working together to meet those goals in product development.
Our team has researched users and developed products for markets all over the world. Learn more about our global perspective:
Continuing the conversation on Design Strategy with a look into our Strategic Concept Vision. Learn how we help our clients evaluate and build upon a prospective future.
What is Design Strategy at Insight Product Development? We’re sharing how we provide value to our clients by leveraging this stage of innovation.
Whether you are looking to incorporate a platform strategy or create a novel device, Insight can supply the resources and expertise to ensure successful outcomes.
Gaining access to facilities and participants for ethnographic research has always been a significant challenge for our clients. Learn how our research team employs a multi-faceted approach to overcoming recruiting challenges to inform medical device development.
ONdrugDelivery Magazine asks Mark Tunkel, Partner and Business Development Director at Insight Product Development, to discuss the benefits of mapping the patient journey when looking to select a platform device for a new drug-device combination product.